Key result
Targeted chemotherapy with RCHOP led to complete remission of primary cardiac lymphoma in a 28-year-old man, with no relapse over a 15-month follow-up period.
Why the study?
Primary cardiac lymphomas are extremely rare cardiac tumors accompanied by poor prognosis unless timely diagnosed and treated.
Case Report (n=1)
No
Targeted chemotherapy can lead to total remission in rare cases of primary cardiac lymphoma.
Answers are grounded in this paper and cite their sources.
May support RCHOP for remission in primary cardiac lymphoma; leaves open need for prospective data in this rare entity.
BACKGROUND: Primary cardiac lymphomas (PCL) represent extremely rare cardiac tumors which are accompanied by poor prognosis, unless they are timely diagnosed and treated. CASE PRESENTATION: Herein we present a 28-year-old, immunocompetent man who presented to our hospital due to progressively worsening symptoms and signs of superior vena cava syndrome. Multi-modality imaging demonstrated a large intracardiac tumor, which was proven, by biopsy, to be a PCL. The patient received targeted chemotherapy which led to total remission of his disease, with no relapse over a 15-month follow-up period. CONCLUSIONS: Although PCLs are rare, they should always be kept in mind in the differential diagnosis of cardiac tumors. Timely diagnosis of PCLs and appropriate chemotherapy, alone or in combination with radiotherapy, seems to provide the best results.
No takes yet. Share an insight, caveat, or question.
Bonou et al. (2019) conducted a case report in Primary cardiac lymphoma (n=1). RCHOP chemotherapy was evaluated on Tumor remission. Targeted chemotherapy with RCHOP led to complete remission of primary cardiac lymphoma in a 28-year-old man, with no relapse over a 15-month follow-up period.
Synapse has enriched 10 related papers. Consider them for comparative context: